We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-5.58%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$11.8B
AUM Growth
-$1.61B
Cap. Flow
-$540M
Cap. Flow %
-4.58%
Top 10 Hldgs %
8.82%
Holding
1,043
New
77
Increased
349
Reduced
381
Closed
85

Top Buys

Rank Stock Value
1
ZD icon
Ziff Davis
ZD
+$62.7M
2
LPX icon
Louisiana-Pacific
LPX
+$24.3M
3
FWRD icon
Forward Air
FWRD
+$20.6M
4
AVLR
Avalara, Inc.
AVLR
+$19.2M
5
RGEN icon
Repligen
RGEN
+$17.1M

Sector Composition

Rank Sector Weight
1 Industrials 26%
2 Technology 19.36%
3 Financials 13.64%
4 Consumer Discretionary 13.09%
5 Materials 8.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNF icon
926
Unifirst Corp
UNF
$5.31B
$298K ﹤0.01%
1,616
-13,245
-89% -$2.45M
TACT icon
927
Transact Technologies
TACT
$50.1M
$289K ﹤0.01%
40,900
BELFB
928
Bel Fuse Inc Class B
BELFB
$3.6B
$279K ﹤0.01%
15,620
-21,381
-58% -$315K
NGNE icon
929
Neurogene
NGNE
$670M
$273K ﹤0.01%
7,270
BMBL icon
930
Bumble
BMBL
$380M
$271K ﹤0.01%
+9,366
New +$259K
MATV icon
931
Mativ Holdings
MATV
$472M
$269K ﹤0.01%
9,773
-14,501
-60% -$437K
MD icon
932
Pediatrix Medical
MD
$2.17B
$260K ﹤0.01%
11,057
-17,985
-62% -$440K
NP
933
DELISTED
Neenah, Inc. Common Stock
NP
$255K ﹤0.01%
6,429
-7,397
-54% -$316K
STKL
934
DELISTED
SunOpta
STKL
$251K ﹤0.01%
50,000
ASPU
935
DELISTED
ASPEN GROUP, INC.
ASPU
$229K ﹤0.01%
141,520
SIF icon
936
SIFCO Industries
SIF
$160M
$227K ﹤0.01%
45,800
JXN icon
937
Jackson Financial
JXN
$8.5B
$221K ﹤0.01%
+4,995
New +$208K
TRHC
938
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$221K ﹤0.01%
38,400
GAN
939
DELISTED
GAN Ltd
GAN
$215K ﹤0.01%
44,700
ASTE icon
940
Astec Industries
ASTE
$1.18B
$208K ﹤0.01%
4,835
-963
-17% -$53.5K
SPOK icon
941
Spok Holdings
SPOK
$225M
$208K ﹤0.01%
26,054
-13,723
-34% -$125K
TISI icon
942
Team
TISI
$79.8M
$206K ﹤0.01%
9,330
AERI
943
DELISTED
Aerie Pharmaceuticals
AERI
$203K ﹤0.01%
22,300
CNVS icon
944
Cineverse
CNVS
$56M
$163K ﹤0.01%
10,000
BNFT
945
DELISTED
Benefitfocus, Inc.
BNFT
$134K ﹤0.01%
10,600
LRMR icon
946
Larimar Therapeutics
LRMR
$398M
$114K ﹤0.01%
28,064
CEMI
947
DELISTED
Chembio diagnostics, Inc.
CEMI
$111K ﹤0.01%
135,800
-178,553
-57% -$167K
SPIR icon
948
Spire Global
SPIR
$440M
$105K ﹤0.01%
+6,250
New +$122K
SQNS
949
Sequans Communications SA
SQNS
$37.1M
$97K ﹤0.01%
1,272
ACCO icon
950
Acco Brands
ACCO
$390M
$83K ﹤0.01%
+10,359
New +$85.9K

Similar funds

Royce & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Royce & Associates held 1,043 positions worth $11.8B, down 12% from $13.4B the previous quarter. Its ten largest holdings account for 8.8% of the portfolio.

Royce & Associates withdrew a net $540M in Q1 2022, closing 85 positions and reducing 381 holdings. Its most notable exit was Canada Goose Holdings, an estimated $21.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 25% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Avalara, Inc. worth $18.9M.

  • Royce & Associates's largest Q1 2022 buy was Avalara, Inc.: 189,630 shares worth $18.9M.
  • Royce & Associates added most to Ziff Davis in Q1 2022, an estimated $62.7M increase.
  • Royce & Associates's biggest Q1 2022 reduction was CMC Materials, Inc. Common Stock, cutting an estimated $42.4M.
  • Royce & Associates fully exited Canada Goose Holdings in Q1 2022, selling an estimated $21.3M.
  • Royce & Associates's ten largest holdings make up 8.8% of its $11.8B portfolio in Q1 2022.
  • Royce & Associates opened 77 new positions and closed 85 in Q1 2022.
  • Royce & Associates's portfolio value fell 12% quarter-over-quarter to $11.8B.

Based on Royce & Associates's 13F filing for Q1 2022, filed 5 May 2022.